Vericel director McLaughlin sells 7,000 shares

Available on EDGAR 11/12/2026 - 07:49 PM EST Accepted by SEC EDGAR 11/12/2026 - 07:48 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Vericel Corp (VCEL) director Kevin F. McLaughlin exercised options for 7,000 shares of common stock on November 10, 2026, at an exercise price of $13.05 per share, acquired 7,000 shares and sold them at $58.96 per share. The sale was effected automatically under a Rule 10b5-1 trading plan adopted May 12, 2025.

Insider Trade Summary 10b5-1

Exercise and Sale: 7,000 shares ($321K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider MCLAUGHLIN KEVIN F

Role Director

Sold 7,000 shs ($413K)

Approx. gross sale proceeds $413K

Approx. exercise cost $91K

Approx. pre-tax spread $321K

Share of Position Sold 27.7%

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	7,000	$0.00	$0.00
Exercise	Common Stock	7,000	$13.05	$91K
Sale	Common Stock F1	7,000	$58.96	$413K

Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Common Stock — 18,300 shares (Direct)

Holdings Before and After: Common Stock, 18,300 to 18,300 shares (Direct)

Other Insiders: 4 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
2. F2. These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

Key Figures

Options exercised: 7,000 options Exercise price: $13.05 per share Shares sold: 7,000 shares +1 more

4 metrics

Options exercised 7,000 options November 10, 2026

Exercise price $13.05 per share Options exercised on November 10, 2026

Shares sold 7,000 shares November 10, 2026

Sale price $58.96 per share Sale on November 10, 2026

Key Terms

Rule 10b5-1 trading plan, exercise price

2 terms

Rule 10b5-1 trading plan regulatory

"automatic sale pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

exercise price financial

"at an exercise price of $13.05"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VCEL shares did director Kevin F. McLaughlin sell, and at what price?

Kevin F. McLaughlin sold 7,000 shares at $58.96 per share on November 10, 2026. On that date, he also exercised options for 7,000 shares at an exercise price of $13.05 per share.

When were Kevin F. McLaughlin’s VCEL options granted, and how did they vest?

The options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018. They became exercisable in equal monthly installments over one year, contingent upon continued service to the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCLAUGHLIN KEVIN F

(Last) (First) (Middle)

C/O VERICEL CORPORATION

25 BLUE SKY DRIVE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2026		M		7,000	A	$13.05	25,300	D
Common Stock	11/10/2026		S		7,000	D(1)	$58.96	18,300	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$13.05	11/10/2026		M		7,000		(2)	05/02/2028	Common Stock	7,000	$0	0	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

2. These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.

	/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)